SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Anastrozole recommended for some post-menopausal women to stop cancer
Fri Dec 13th - Anastrozole should be the preventive drug recommended for post-menopausal women at increased risk of developing breast cancer, according to the findings of a new international study today. More
Blood test identifies rare breast cancer mutations
Fri Dec 13th - Rare mutations in advanced breast cancer can be identified through a simple blood test, in what clinicians have described as a “huge step”, it was announced last night. More
Infertility risk for boys who are born small
Fri Dec 13th - Boys who are born small for their gestational age have an increased risk of fertility problems in adulthood, a Danish study published today (13 December 2019) has claimed. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Leprosy research breakthrough

Friday August 25th, 2017

British and US researchers have made a breakthrough in the study of leprosy - explaining for the first time how the disease causes its damage, it was announced last night.

The research shows that the Mycobacterium leprae disrupts the immune system, leading it to destroy the myelin sheath protecting the nervous system.

The study, based on research on zebrafish, is reported in <i>Cell</i> by researchers from Cambridge University, UK, and in the USA, Harvard, UCLA and the University of Washington.

The researchers found that macrophages in the immune system consumed the bacteria but sometimes failed to destroy them.

This led the macrophages settling on the nerve fibre and destroying the myelin sheath, rather than repairing damage.

Researcher Professor Lalita Ramakrishnan, from Cambridge, UK, said: “The leprosy bacteria are, essentially, hijacking an important repair mechanism and causing it to go awry.

“It then starts spewing out toxic chemicals. Not only does it stop repairing damage, but it creates more damage itself.”

The researchers are unsure whether their findings can be used to improve treatments.

Professor Ramakrishnan said: “At the moment, leprosy can be treated by a combination of drugs. While these succeed in killing the bacteria, once the nerve damage has been done, it is currently irreversible. We would like to understand how to change that.

"In other words, are we able to prevent damage to nerve cells in the first place and can we additionally focus on repairing damaged nerve cells?”

Madigan, CA et al. A Macrophage Response To Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage In Leprosy. Cell 24 Aug 2017; doi: 10.1016/j.cell.2017.07.030

Tags: Dermatology | North America | UK News | World Health

Printer friendly page Printer friendly page

Comments

1At 12/09/2017 05:50am Aparna srikantam wrote

Brilliant finding! indeed a break through in understanding how Mycobacterium leprae hijacks the human immune system. I am hopeful this finding shows light on many unsolved puzzles in controlling/preventing leprosy related clinical complications

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES